| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.06T | 1.13T | 1.16T | 1.13T | 911.43B | 863.38B |
| Gross Profit | 446.90B | 479.42B | 504.68B | 485.94B | 392.74B | 374.65B |
| EBITDA | 56.95B | -60.74B | 106.18B | -16.80B | 60.35B | 66.32B |
| Net Income | -14.52B | -47.85B | 4.52B | -103.15B | -26.12B | -15.21B |
Balance Sheet | ||||||
| Total Assets | 1.19T | 1.22T | 1.39T | 1.41T | 1.34T | 1.30T |
| Cash, Cash Equivalents and Short-Term Investments | 120.36B | 89.90B | 127.13B | 183.06B | 117.67B | 123.82B |
| Total Debt | 411.30B | 438.17B | 522.58B | 568.29B | 448.65B | 410.70B |
| Total Liabilities | 684.70B | 743.56B | 834.67B | 913.90B | 776.62B | 749.05B |
| Stockholders Equity | 495.69B | 463.15B | 539.82B | 487.42B | 549.81B | 539.89B |
Cash Flow | ||||||
| Free Cash Flow | 5.04B | 25.30B | 38.21B | -27.46B | -23.61B | 37.86B |
| Operating Cash Flow | 48.38B | 51.09B | 83.34B | 13.32B | 37.44B | 78.06B |
| Investing Cash Flow | 22.49B | 24.65B | -44.53B | -37.50B | -51.00B | -34.33B |
| Financing Cash Flow | -87.64B | -110.90B | -96.85B | 84.32B | 2.13B | -13.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥754.76B | 18.94 | 10.63% | 2.03% | 5.40% | 23.70% | |
76 Outperform | $811.48B | 14.74 | 7.77% | 3.16% | 4.30% | 78.29% | |
74 Outperform | ¥807.53B | 13.33 | 5.91% | 2.78% | 4.46% | 70.22% | |
72 Outperform | ¥3.97T | 14.70 | 7.92% | 2.07% | 5.39% | 12.69% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | $346.08B | -24.55 | -12.69% | 0.71% | -11.22% | -731.07% |
Konica Minolta reported its consolidated financial results for the six months ending September 30, 2025, showing a revenue of 513,160 million yen, an 8% decrease from the previous year. Despite the revenue drop, the company saw a significant improvement in business contribution profit, operating profit, and profit attributable to owners, reflecting a positive turnaround in its financial performance. The company’s equity ratio also improved to 41.6%, indicating a stronger financial position. The announcement highlights the discontinuation of the Precision Medicine Business, focusing on continuing operations, and a dividend of 5 yen per share for the fiscal year ending March 31, 2026, signaling a commitment to shareholder returns.
The most recent analyst rating on (JP:4902) stock is a Hold with a Yen529.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.